Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signal transduction in ischemic preconditioning

J M Downey1, M V Cohen

  • 1Department of Physiology, University of South Alabama, College of Medicine, Mobile 36688, USA.

Advances in Experimental Medicine and Biology
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection.

Basic research in cardiology·2016
Same author

Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood.

Cardiovascular drugs and therapy·2015
Same author

Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques.

Radiation research·2012
Same author

Ischemic preconditioning Nature's own cardioprotective intervention.

Trends in cardiovascular medicine·2011
Same author

Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination?

Archives des maladies du coeur et des vaisseaux·2007
Same author

Cardioprotection: spotlight on PKG.

British journal of pharmacology·2007

Ischemic preconditioning protects the heart against infarction by activating a kinase cascade. Understanding this phenomenon could lead to new treatments for acute myocardial infarction.

Area of Science:

  • Cardiovascular Physiology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Ischemic preconditioning confers resistance to myocardial infarction following brief ischemic insults.
  • The precise molecular mechanisms underlying this protective phenomenon remain incompletely understood.

Purpose of the Study:

  • To elucidate the signaling pathways involved in ischemic preconditioning.
  • To identify potential therapeutic targets for protecting the heart during acute myocardial infarction.

Main Methods:

  • Investigated the role of specific receptors (adenosine, opioid, bradykinin) and free radical generation in triggering preconditioning.
  • Examined the involvement of protein kinase C (PKC) and tyrosine kinase activation.
  • Explored downstream effectors, including potassium channels and cytoskeletal proteins.

Related Experiment Videos

Main Results:

  • Preconditioning ischemia activates adenosine, opioid, and bradykinin receptors, alongside free radical generation.
  • These signals converge to activate protein kinase C (PKC) and a subsequent tyrosine kinase cascade.
  • The kinase cascade culminates in an unknown effector, potentially a potassium channel or cytoskeletal protein, conferring infarction resistance.

Conclusions:

  • Ischemic preconditioning involves a complex kinase cascade initiated by receptor activation and free radicals.
  • Understanding this pathway is crucial for developing strategies to protect the heart during myocardial infarction.